incretin hormone glp-1 hormones and the satiation signal Targeting both incretin receptors together

GIPR monoagonism drives weight loss and food intake reduction on its own in both humans (52) and rodents (5355)

Two years after stopping treatment, patients who had received higher doses had lower risks of death from any cause, as well as reduced risks of heart attack, stroke, cardiovascular-related death, heart failure, and heart valve problems

GLP-1 receptor stimulation reduces amyloid- peptide accumulation and cytotoxicity in cellular and animal models of alzheimers disease

This is more pronounced when the dose of the GLP-1 is being adjusted or produces side effects like vomiting

Learn more about our weight loss injection program below

When you lose weight fast, your body produces less collagen